(elexacaftor + ivacaftor + tezacaftor) + ivacaftor
Marketedupdated 2mo agoby $VERX Vertex, Inc.
Approvedannual revenue · 2024–2024peak $11.0B
community read0 votes
indications
investigational
Cystic Fibrosis
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that